Logo image of SABE.PA

SAINT JEAN GROUPE SA (SABE.PA) Stock Fundamental Analysis

Europe - EPA:SABE - FR0000060121 - Common Stock

19 EUR
-0.3 (-1.55%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SABE. SABE was compared to 58 industry peers in the Food Products industry. The financial health of SABE is average, but there are quite some concerns on its profitability. SABE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SABE was profitable.
In the past year SABE had a positive cash flow from operations.
In the past 5 years SABE has always been profitable.
In the past 5 years SABE always reported a positive cash flow from operatings.
SABE.PA Yearly Net Income VS EBIT VS OCF VS FCFSABE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

The Return On Assets of SABE (1.21%) is worse than 68.97% of its industry peers.
The Return On Equity of SABE (2.64%) is worse than 67.24% of its industry peers.
The Return On Invested Capital of SABE (0.74%) is worse than 79.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SABE is significantly below the industry average of 7.05%.
Industry RankSector Rank
ROA 1.21%
ROE 2.64%
ROIC 0.74%
ROA(3y)1.32%
ROA(5y)1.25%
ROE(3y)3.01%
ROE(5y)2.68%
ROIC(3y)1.23%
ROIC(5y)1.21%
SABE.PA Yearly ROA, ROE, ROICSABE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

SABE's Profit Margin of 1.72% is on the low side compared to the rest of the industry. SABE is outperformed by 62.07% of its industry peers.
In the last couple of years the Profit Margin of SABE has declined.
SABE has a worse Operating Margin (1.18%) than 79.31% of its industry peers.
In the last couple of years the Operating Margin of SABE has declined.
SABE has a Gross Margin of 35.13%. This is comparable to the rest of the industry: SABE outperforms 46.55% of its industry peers.
SABE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.18%
PM (TTM) 1.72%
GM 35.13%
OM growth 3Y-18.97%
OM growth 5Y-12.42%
PM growth 3Y-4.9%
PM growth 5Y-18.34%
GM growth 3Y-0.46%
GM growth 5Y-1.77%
SABE.PA Yearly Profit, Operating, Gross MarginsSABE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SABE is destroying value.
Compared to 1 year ago, SABE has about the same amount of shares outstanding.
The number of shares outstanding for SABE has been reduced compared to 5 years ago.
Compared to 1 year ago, SABE has an improved debt to assets ratio.
SABE.PA Yearly Shares OutstandingSABE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
SABE.PA Yearly Total Debt VS Total AssetsSABE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

SABE has an Altman-Z score of 1.97. This is not the best score and indicates that SABE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SABE (1.97) is comparable to the rest of the industry.
SABE has a Debt/Equity ratio of 0.66. This is a neutral value indicating SABE is somewhat dependend on debt financing.
SABE has a Debt to Equity ratio (0.66) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACC0.13
WACC5.78%
SABE.PA Yearly LT Debt VS Equity VS FCFSABE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

SABE has a Current Ratio of 2.04. This indicates that SABE is financially healthy and has no problem in meeting its short term obligations.
SABE has a Current ratio of 2.04. This is in the better half of the industry: SABE outperforms 77.59% of its industry peers.
SABE has a Quick Ratio of 1.70. This is a normal value and indicates that SABE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.70, SABE belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.7
SABE.PA Yearly Current Assets VS Current LiabilitesSABE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SABE have decreased strongly by -52.15% in the last year.
SABE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.41% yearly.
SABE shows a small growth in Revenue. In the last year, the Revenue has grown by 1.02%.
The Revenue has been growing slightly by 7.46% on average over the past years.
EPS 1Y (TTM)-52.15%
EPS 3Y3.48%
EPS 5Y-11.41%
EPS Q2Q%-84.15%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y7.11%
Revenue growth 5Y7.46%
Sales Q2Q%1.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SABE.PA Yearly Revenue VS EstimatesSABE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.16, the valuation of SABE can be described as expensive.
Based on the Price/Earnings ratio, SABE is valued a bit more expensive than the industry average as 62.07% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.20, SABE is valued at the same level.
Industry RankSector Rank
PE 30.16
Fwd PE N/A
SABE.PA Price Earnings VS Forward Price EarningsSABE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SABE is valued a bit cheaper than the industry average as 68.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.79
SABE.PA Per share dataSABE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

SABE has a yearly dividend return of 0.50%, which is pretty low.
SABE's Dividend Yield is slightly below the industry average, which is at 3.27.
Compared to an average S&P500 Dividend Yield of 2.38, SABE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

The dividend of SABE decreases each year by -14.70%.
Dividend Growth(5Y)-14.7%
Div Incr Years0
Div Non Decr Years2
SABE.PA Yearly Dividends per shareSABE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

SABE pays out 15.81% of its income as dividend. This is a sustainable payout ratio.
SABE's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP15.81%
EPS Next 2YN/A
EPS Next 3YN/A
SABE.PA Yearly Income VS Free CF VS DividendSABE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M
SABE.PA Dividend Payout.SABE.PA Dividend Payout, showing the Payout Ratio.SABE.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SAINT JEAN GROUPE SA

EPA:SABE (9/16/2025, 7:00:00 PM)

19

-0.3 (-1.55%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.41%
Ins Owner ChangeN/A
Market Cap60.80M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend0.1
Dividend Growth(5Y)-14.7%
DP15.81%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.16
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF 5.71
P/B 0.8
P/tB 0.87
EV/EBITDA 6.79
EPS(TTM)0.63
EY3.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)3.33
OCFY17.51%
SpS36.51
BVpS23.83
TBVpS21.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 2.64%
ROCE 1.01%
ROIC 0.74%
ROICexc 0.99%
ROICexgc 1.05%
OM 1.18%
PM (TTM) 1.72%
GM 35.13%
FCFM N/A
ROA(3y)1.32%
ROA(5y)1.25%
ROE(3y)3.01%
ROE(5y)2.68%
ROIC(3y)1.23%
ROIC(5y)1.21%
ROICexc(3y)1.73%
ROICexc(5y)1.82%
ROICexgc(3y)1.85%
ROICexgc(5y)1.97%
ROCE(3y)1.67%
ROCE(5y)1.64%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-20.1%
ROICexc growth 3Y-21.76%
ROICexc growth 5Y-18.9%
OM growth 3Y-18.97%
OM growth 5Y-12.42%
PM growth 3Y-4.9%
PM growth 5Y-18.34%
GM growth 3Y-0.46%
GM growth 5Y-1.77%
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Debt/EBITDA 3.97
Cap/Depr 120.52%
Cap/Sales 11.59%
Interest Coverage 250
Cash Conversion 84.42%
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.7
Altman-Z 1.97
F-Score7
WACC5.78%
ROIC/WACC0.13
Cap/Depr(3y)230.83%
Cap/Depr(5y)238.47%
Cap/Sales(3y)16.15%
Cap/Sales(5y)16.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.15%
EPS 3Y3.48%
EPS 5Y-11.41%
EPS Q2Q%-84.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.02%
Revenue growth 3Y7.11%
Revenue growth 5Y7.46%
Sales Q2Q%1.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.87%
EBIT growth 3Y-13.22%
EBIT growth 5Y-5.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.88%
OCF growth 3Y8.5%
OCF growth 5Y8.59%